Company intelligence / Profile preview

FetalFirst

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

FetalFirst offers a commercial AI-driven platform for secure medical data upload, AI-based fetal risk prediction, and expert second opinion consultations in fetal medicine. There is no direct evidence of clinical trial data or medicinal products; its core offering is a regulated support service for patients and clinicians rather than a drug or biologic.

Therapeutic areas: Women's HealthNeurologyRare Diseases
Modalities: DeviceAI-powered clinical decision support
Industry: Digital Health Medical Devices

Partnerships

Hospitals and research institutions (unspecified)Medical specialists in fetal medicine and genetics

Beyond the preview

Go deeper on FetalFirst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FetalFirst.

Explore the full profile